Reference health

Gender-specific association of ATP-binding cassette transporter 1 (ABCA1) polymorphisms with the risk of late-onset Alzheimer's disease

https://doi.org/10.1016/j.neurobiolaging.2006.04.005

33/33 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

The 33 checked references that resolve

resolves10.1056/NEJMoa042765

Family-Based Association between Alzheimer's Disease and Variants in<i>UBQLN1</i>

resolves10.1093/hmg/ddg007

Results of a high-resolution genome screen of 437 Alzheimer's Disease families

resolves10.1016/j.mrfmmm.2004.08.017

Genetic association analysis: lessons from the study of Alzheimers Disease

resolves10.1023/B:NERE.0000042217.90204.8d

Effects of Lovastatin and Pravastatin on Amyloid Processing and Inflammatory Response in TgCRND8 Brain

resolves10.1161/01.CIR.103.9.1198

Common Genetic Variation in <i>ABCA1</i> Is Associated With Altered Lipoprotein Levels and a Modified Risk for Coronary Artery Disease

resolves10.1126/science.1099870

Multiple Rare Alleles Contribute to Low Plasma Levels of HDL Cholesterol

resolves10.1016/j.neulet.2005.01.008

Investigation of the effect of brain-derived neurotrophic factor (BDNF) polymorphisms on the risk of late-onset Alzheimer's disease (AD) and quantitative measures of AD progression

resolves10.1007/s00109-003-0426-y

The association of the R219K polymorphism in the ATP-binding cassette transporter 1 (ABCA1) gene with coronary heart disease and hyperlipidaemia

resolves10.1001/jama.1997.03550160069041

Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease

resolves10.1212/WNL.59.8.1257

Effects of statins on human cerebral cholesterol metabolism and secretion of Alzheimer amyloid peptide

resolves10.1016/0022-3956(75)90026-6

“Mini-mental state”

resolves10.1074/jbc.M407962200

Deficiency of ABCA1 Impairs Apolipoprotein E Metabolism in Brain

resolves10.1074/jbc.M508781200

The Absence of ABCA1 Decreases Soluble ApoE Levels but Does Not Diminish Amyloid Deposition in Two Murine Models of Alzheimer Disease

resolves10.1159/000084550

The Effect of Simvastatin Treatment on the Amyloid Precursor Protein and Brain Cholesterol Metabolism in Patients with Alzheimer’s Disease

resolves10.1080/10618600.1996.10474713

R: A Language for Data Analysis and Graphics

resolves10.1038/sj.mp.4001775

Genetic association of ubiquilin with Alzheimer's disease and related quantitative measures

resolves10.1002/humu.20012

Genetic variants ofABCA1 modify Alzheimer disease risk and quantitative traits related to ?-amyloid metabolism

resolves10.1007/s10038-005-0341-x

Quantitative trait loci in ABCA1 modify cerebrospinal fluid amyloid-β1-42 and plasma apolipoprotein levels

resolves10.1093/hmg/8.2.237

A full genome scan for late onset Alzheimer's disease

resolves10.1074/jbc.M504513200

Lack of ABCA1 Considerably Decreases Brain ApoE Level and Increases Amyloid Deposition in APP23 Mice

resolves10.1016/j.atherosclerosis.2003.08.014

Heterozygosity for ABCA1 gene mutations: effects on enzymes, apolipoproteins and lipoprotein particle size

resolves10.1016/j.neulet.2004.05.047

Association of ABCA1 with late-onset Alzheimer’s disease is not observed in a case-control study

resolves10.1212/WNL.34.7.939

Clinical diagnosis of Alzheimer's disease

resolves10.1002/ajmg.10183

Full genome screen for Alzheimer disease: Stage II analysis*

resolves10.1016/S1388-1981(00)00157-8

Tangier disease and ABCA1

resolves10.1016/S0531-5565(00)00196-0

Identification of Novel Genes in Late-Onset Alzheimer's Disease

resolves10.1006/nbdi.2000.0304

Hypercholesterolemia Accelerates the Alzheimer's Amyloid Pathology in a Transgenic Mouse Model

resolves10.1023/A:1020604610873

Estrogen-induced regulation of the ATP-binding cassette transporter A1 (ABCA1) in mice: A possible mechanism of atheroprotection by estrogen

resolves10.1074/jbc.M407963200

ABCA1 Is Required for Normal Central Nervous System ApoE Levels and for Lipidation of Astrocyte-secreted apoE

resolves10.1074/jbc.M508780200

Deletion of Abca1 Increases Aβ Deposition in the PDAPP Transgenic Mouse Model of Alzheimer Disease

resolves10.1111/j.0009-9163.2004.00280.x

Cholesterol at the crossroads: Alzheimer's disease and lipid metabolism

resolves10.1016/S0197-4580(02)00094-5

ABCA1 modulates CSF cholesterol levels and influences the age at onset of Alzheimer's disease

resolves10.1001/archneur.57.10.1439

Decreased Prevalence of Alzheimer Disease Associated With 3-Hydroxy-3-Methyglutaryl Coenzyme A Reductase Inhibitors

What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

view as graph · paper page

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1016/j.neurobiolaging.2006.04.005"><img src="https://citestamp.com/citestamped/10.1016/j.neurobiolaging.2006.04.005/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>

[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1016/j.neurobiolaging.2006.04.005/badge.svg)](https://citestamp.com/citestamped/10.1016/j.neurobiolaging.2006.04.005)